Product Name: ELOVL3 antibody
Applications: ELISA, IHC-P
Predicted Target Size: 31 kDa (note)
Positive Controls:
Form Supplied:
Concentration:
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Full Name: elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3
Background: Participates in the formation of certain very long chain fatty acids and triglycerides in certain cells of the hair follicles and the sebaceous glands, required for skin barrier function. May catalyze one or both of the reduction reaction in fatty acid elongation, i.e. conversion of beta-ketoacyl CoA to beta-hydroxyacyl CoA or reduction of trans-2-enoyl CoA to the saturated acyl CoA derivative.
Synonyms: Coldinducible glycoprotein of 30 kDa, ELOVL3, Elongation of very long chain fatty acids protein3, Coldinducible glycoprotein of30 kDa, Cold-inducible glycoprotein of 30 kDa, Elongation of very long chain fatty acids protein 3
Cellular Localization:
CAS NO: 405168-58-3
Product: Laropiprant
Host: Rabbit
Clonality: Polyclonal
Isotype:
Immunogen: The antiserum was produced against synthesized peptide derived from human ELOVL3.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 200% glycerol.
Storage Instruction: Store at -20 degrees Celcius. Product is stable for at least 1 year.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity: ELOVL3 Antibody detects endogenous levels of total ELOVL3 protein.
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/25855537?dopt=Abstract
